SVP, Global Head DTA Oncology

İsviçre, Basel Şehri, Basel

en de fr es ru it pt zh ja

Reporting directly to the Head of pRED, Dr. William Pao, we are seeking an SVP, Global Head of the Oncology Discovery and Translational Area (DTA) unit (“DTA Oncology pRED”) who will have the strategic and operational leadership for this important disease area. This senior vice president will be responsible for crafting and implementing the strategic and operational oncology R&D plans in alignment with the overall R&D plan. The executive will lead all aspects of the organization and influence new technologies and science. The executive should be a forward-thinking leader ready to develop an outstanding Oncology research and early development organization that delivers extraordinary science and a rich pipeline of products for the benefit of the patients of the world. The DTA Oncology group has approximately 270 scientists across 4 sites (Munich, Zurich, Basel, and Welwyn).

Given the importance of Oncology for Roche, the Head of DTA Oncology pRED will be a globally visible position who is regularly called upon to represent Roche regarding its science and pipeline to the external world.

Candidate profile

This position is clearly one of the most senior and impactful Oncology research roles in the pharmaceutical industry, where there will be an immense opportunity to positively affect human health. The ideal candidate will be a top leader in the field of Oncology research and early development, bringing an impressive and significant track record of publications, drug development success and/or thought leadership, either from academia or industry. The executive will have a global attitude with the ability to work effectively in highly international and diverse multi-cultural organizations of a significant size. An MD or MD/PhD is preferred.


The ideal candidate will have proven competence in the following areas:

  • Scientific Credibility – The candidate will have an outstanding reputation and recognition in the oncology / cancer immunotherapy scientific community.

  • Results Orientation – The candidate will have a proven record of encouraging others in the pursuit of new insights in the search for cures in the sophisticated area of oncology.

  • Team Leadership, Attracting Talent and Developing People – The new leader will bring a track record of establishing an environment and reputation that attracts, develops, and encourages this talent. He/she will be able to develop a clear team spirit and to instill a culture of success across the DTA Oncology organization.

  • Collaboration and Influencing – The role requires an executive with a desire to work with peers, partners and others who are not in the line-of-command in order to improve performance and meet goals. This person has a track record of encouraging and overseeing, multiple successful relationships across academic institutions and industry partners, specifically for early discovery alliances.

  • Strategic/ Innovative Thinking – The candidate will demonstrate the ability to articulate evolving priorities and technologies/targets and strategies for oncology treatment within a long term horizon and will encourage and focus his/her organization.


The role will be based in Basel, Switzerland and will, when more routine travel resumes, require extensive travel to multiple company sites including South San Francisco, CA.

Roche is an equal opportunity employer.

Araştırma ve Geliştirme, Araştırma ve Geliştirme > Araştırma ve Erken Gelişim